Your browser doesn't support javascript.
loading
Efficacy and Safety of Infliximab Retreatment in Crohn's Disease: A Multicentre, Prospective, Observational Cohort (REGAIN) Study from the GETAID.
Boschetti, Gilles; Nachury, Maria; Laharie, David; Roblin, Xavier; Gilletta, Cyrielle; Aubourg, Alexandre; Bourreille, Arnaud; Zallot, Camille; Hebuterne, Xavier; Buisson, Anthony; Grimaud, Jean-Charles; Bouhnik, Yoram; Allez, Matthieu; Altwegg, Romain; Viennot, Stéphanie; Vuitton, Lucine; Carbonnel, Franck; Paul, Stéphane; Desseaux, Kristell; Lambert, Jérome; Peyrin-Biroulet, Laurent.
Afiliação
  • Boschetti G; Department of Gastroenterology, Lyon-Sud Hospital, Hospices Civils de Lyon, Université Claude Bernard Lyon1, INSERM U1111, CIRI, Centre International de Recherche en Infectiologie, Lyon, France.
  • Nachury M; Univ. Lille, Inserm, CHU Lille, U1286-INFINITE-Institute for Translational Research in Inflammation, Lille, France.
  • Laharie D; CHU de Bordeaux, Hôpital Haut-Lévêque, Service d'Hépato-Gastroentérologie et Oncologie Digestive, Université de Bordeaux, Bordeaux, France.
  • Roblin X; Department of Gastroenterology, University Hospital of Saint Etienne, Saint Etienne, France.
  • Gilletta C; Department of Gastroenterology, University Hospital Rangueuil, Toulouse Cedex 9, France.
  • Aubourg A; Department of Hepato-Gastroenterology and Oncology, CHRU Trousseau, Tours, France.
  • Bourreille A; CHU Nantes, Institut des Maladies de L'Appareil Digestif (IMAD), Department of Gastroenterology, CIC Inserm 1413, University of Nantes, Nantes, France.
  • Zallot C; Department of Hepato-Gastroenterology and Inserm NGERE, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
  • Hebuterne X; Department of Gastroenterology, University Hospital L'Archet, Nice, France.
  • Buisson A; Department of Gastroenterology, Estaing Hospital, Clermont-Ferrand University, France.
  • Grimaud JC; Gastroenterology Department, Assistance Publique Hôpitaux de Marseille, Centre Hospitalier Universitaire of Marseille, Marseille, France.
  • Bouhnik Y; Department of Gastroenterology, Beaujon University Hospital, Clichy, France.
  • Allez M; Department of Gastroenterology, Hôpital Saint-Louis, APHP, Université de Paris, Paris, France.
  • Altwegg R; Department of Hepatology and Gastroenterology, University Hospital of St Eloi, Montpellier, France.
  • Viennot S; Department of Gastroenterology, Caen University Hospital, Caen, France.
  • Vuitton L; Department of Gastroenterology, Besancon University Hospital, Besancon, France.
  • Carbonnel F; Department of Gastroenterology, Bicetre University Hospital, APHP, Université Paris Sud, le Kremlin Bicêtre, Paris, France.
  • Paul S; Immunology and Immunomonitoring Laboratory, Laboratoire National de Référence IBiothera; CIRI, Centre International de Recherche en Infectiologie, Team GIMAP, Univ Lyon, Université Claude Bernard Lyon 1, Inserm, U1111, CNRS, UMR530, CIC 1408 Vaccinology, Saint-Etienne, France.
  • Desseaux K; Department of Biostatistics and Medical Information, APHP, Saint-Louis Hospital, Paris, France.
  • Lambert J; Department of Biostatistics and Medical Information, APHP, Saint-Louis Hospital, Paris, France.
  • Peyrin-Biroulet L; Department of Hepato-Gastroenterology and Inserm NGERE, University Hospital of Nancy, University of Lorraine, Vandoeuvre-lès-Nancy, France.
Am J Gastroenterol ; 117(9): 1482-1490, 2022 09 01.
Article em En | MEDLINE | ID: mdl-35973142

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Crohn Idioma: En Ano de publicação: 2022 Tipo de documento: Article